Oracle
ORCL
Netflix
NFLX
Meta Platforms
META
4
Apple
AAPL
5
Tesla
TSLA
US Stock MarketDetailed Quotes
BDTX Black Diamond Therapeutics
- 1.600
- +0.010+0.63%
Close Apr 28 16:00 ET
- 1.620
- +0.020+1.25%
Pre 09:10 ET
90.68MMarket Cap-1.26P/E (TTM)
1.640High1.565Low664.55KVolume1.590Open1.590Pre Close1.07MTurnover1.70%Turnover RatioLossP/E (Static)56.68MShares7.66052wk High1.09P/B62.40MFloat Cap1.19552wk Low--Dividend TTM39.00MShs Float46.250Historical High--Div YieldTTM4.72%Amplitude1.180Historical Low1.604Avg Price1Lot Size
About Black Diamond Therapeutics Company
Black Diamond Therapeutics, Inc. is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The company’s MasterKey therapies are designed to address a broad spectrum of genetically defined tumors, overcome resistance, minimize wild-type-mediated toxicities, and be brain-penetrant to treat central nervous system diseases. It is currently focused on advancing a Phase 2 NSCLC trial of BDTX-1535, a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor targeting EGFR-mutant NSCLC and glioblastoma. The company was founded by David M. Epstein and Elizabeth Buck in 2014 and is headquartered in Cambridge, MA.
Company Profile
SymbolBDTX
Company NameBlack Diamond Therapeutics
Listing DateJan 30, 2020
Issue Price19.00
Founded2014
CEODr. Mark A. Velleca, M.D.
MarketNASDAQ
Employees24
Fiscal Year Ends12-31
AddressOne Main Street,14th floor
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-252-0848
Company Executives
- Name
- Position
- Salary
- Dr. Mark A. Velleca, M.D.
- Chairman of the Board, President and Chief Executive Officer
- 2.86M
- Melanie Morrison
- Chief Development Officer
- --
- Elizabeth Buck, PhD
- Chief Scientific Officer
- --
- Sergey Yurasov, M.D.,Pd.D
- Chief Medical Officer
- 1.51M
- Brent Hatzis-Schoch, Esq.
- Chief Operating Officer and General Counsel
- 1.41M
- Erika Jones
- Senior Vice President, Finance, Principal Financial Officer and Principal Accounting Officer
- --
- Shannon Campbell, PhD
- Independent Director
- 352.20K
- Dr. Samarth Kulkarni, PhD
- Lead Independent Director
- 171.35K
- Dr. Prakash Raman, PhD
- Independent Director
- 356.90K
- Dr. Kapil Dhingra, M.B.B.S.
- Independent Director
- 186.75K
- Dr. Garry E. Menzel, PhD
- Independent Director
- 162.35K
- Dr. Ali Behbahani, M.B.A.,M.D.
- Independent Director
- 159.85K
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀